Skip to main content
. 2017 Mar 9;7:44123. doi: 10.1038/srep44123

Figure 3. Resistance of sorafenib in BRAFWT HCC cells is due to degradation of Bim.

Figure 3

(a) Bim phosphorylation in BRAFWT HCC cells 24 hours after BRAF inhibition with sorafenib. (b) Bim degradation in BRAFWT HCC cells 48 hours after BRAF inhibition with sorafenib. Inhibition of ERK increases apoptosis (c) and decreases Bim degradation after sorafenib treatment in BRAFWT HCC cells in vitro (d) and in spontaneously arising HCCs in Mst1−/−Mst2Flox/− mice in vivo (e).